news, journals and articles from all over the world.
A partir de 2021, The Allergists’ Foundation, el brazo filantrópico del Colegio Americano de Alergia, Asma e Inmunología, comenzó a financiar proyectos innovadores que abordan los desafíos que enfrentan las comunidades atendidas por alergólogos en ejercicio.
Los padres de niños con dermatitis atópica (DA, también llamada eczema) saben que la condición alérgica puede significar un mayor riesgo de desarrollar alergias alimentarias. El deseo de prevenir las alergias alimentarias hace que algunos padres consideren dietas de eliminación, eliminando ciertos alimentos de la dieta de sus hijos. Un nuevo estudio presentado en la Reunión Científica Anual del Colegio Americano de Alergia, Asma e Inmunología (ACAAI) de este año en Boston mostró que las dietas de eliminación en el caso de la dermatitis atópica solo mejoraron levemente las lesiones de DA en un tercio de los participantes del estudio.
Beginning in 2021, The Allergists’ Foundation, the philanthropic arm of the American College of Allergy, Asthma and Immunology, began funding innovative projects that address challenges faced by communities served by practicing allergists.
Parents of children with atopic dermatitis (AD, also called eczema) know that the allergic condition can mean a heightened risk of developing food allergies. The desire to prevent food allergies causes some parents to consider elimination diets, cutting out certain foods from their child’s diet. A new study being presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Boston showed that elimination diets in the case of atopic dermatitis only mildly improved AD lesions in one-third of the study participants.
First-of-its-kind clinical trial with specific JAK inhibition will investigate the best treatment for inflammatory skin conditions in these patients
Up to 15 percent of children and five percent of adults are affected by the chronic inflammatory skin disease atopic dermatitis. Despite advanced therapy measures, the severe itching and eczema, especially on the elbows or knees, cause great distress to the patients.
Eczema, which is a group of medical conditions that causes inflamed, irritated, and often itchy skin, affects millions of people worldwide. A new article published in the reveals that children diagnosed with a type of eczema called atopic dermatitis — which they usually develop by 5 years of age — may also need to be tested for a second type of eczema called allergic contact dermatitis, which has similar symptoms and can be triggered by a range of substances that cause an allergic reaction.
Adults with atopic dermatitis (AD) have a 34 percent increased risk of developing new-onset inflammatory bowel disease (IBD) compared with individuals who do not have the skin condition, and children have a 44 percent increased risk, according to a new study from the Perelman School of Medicine at the University of Pennsylvania.
Atopic dermatitis (AD) is a chronic, inflammatory skin disorder that has well-established associations with depression and anxiety. A new Yale School of Medicine study finds AD is also associated with increased risk for schizophrenia and shizoaffective disorder. Schizophrenia is a…
According to a new Finnish study, greenness around the home in early childhood does not seem to protect children from atopic eczema. Instead, the proximity of coniferous, mixed forests and agricultural areas was associated with elevated risk of eczema. The effect was seen especially in children who were born in the spring.
Mount Sinai researchers have been awarded $12 million over five years by the National Institutes of Health to create a center to elucidate novel causes of, and contributing factors to, food allergies and atopic dermatitis. The Systems Biology of Early Atopy (SunBEAm) Analysis and Bioinformatics Center intends to develop a better understanding of allergy development. The center will apply systems biology to identify early-life markers of risk for food allergies and atopic dermatitis (also known as eczema), as well as biological pathways underlying these common conditions, through the profiling and analysis of longitudinal multi-omics data from a multi-center pre-birth cohort of 2,500 children.
ROSEMONT, Ill. (January 11, 2023) — Often called eczema or atopic eczema, atopic dermatitis is a common skin condition, affecting 1 in 10 Americans. Although atopic dermatitis occurs most frequently in children, it also affects adults and can have a significant impact on patients’ quality of life. To help ensure that adult patients with atopic dermatitis receive the best possible treatment, the American Academy of Dermatology (AAD) has published updated guidelines of care for the management of atopic dermatitis in adults with topical therapies in the y.
This systematic review and meta-analysis in the Journal of Allergy and Clinical Immunology provides moderate-certainty evidence that adjunctive allergen immunotherapy results in important improvements in atopic dermatitis severity and quality of life. This supports a multidisciplinary and shared-decision making approach to optimal atopic…
Two recent UC Davis studies reveal how skin forms differently across different areas of the body from the face and underarms to the palms of our hands and feet. By profiling the changes in skin, researchers found that the differences have a direct impact for how various skin diseases form across the body.
JMIR Publications recently published “Effectiveness of Pediatric Teleconsultation to Prevent Skin Conditions in Infants and Reduce Parenting Stress in Mothers: Randomized Controlled Trial” in JMIR Pediatrics and Parenting which reported that mothers of infants are prone to experiencing parenting stress, which adversely affects mothers’ and children’s well-being. Additionally, studies have reported that atopic dermatitis (AD) among offspring enhances parenting stress, and postnatal maternal psychological problems can increase the risk of AD in children.
An oral medication called upadacitinib yielded rapid and significant improvements in patients with moderate to severe atopic dermatitis (AD), also known as eczema, in phase 3 clinical trials, Mount Sinai researchers reported today in The Lancet online.
Researchers at UC San Diego School of Medicine use bacteriotherapy to improve symptoms of atopic dermatitis.
New research from Washington University School of Medicine in St. Louis indicates that allergens in the environment often are to blame for episodes of acute itch in eczema patients, and that the itching often doesn’t respond to antihistamines because the itch signals are being carried to the brain along a previously unrecognized pathway that current drugs don’t target.
Mount Sinai researchers have pinpointed a single gene biomarker, nitride oxide synthase 2 (NOS2) that can distinguish atopic dermatitis (AD) and psoriasis with 100 percent accuracy using adhesive tape strips, a non-invasive alternative to skin biopsy. The research will be published online today in the Journal of Allergy and Clinical Immunology.
The study will aim to understand whether systemic medications and biologics, such as dupilumab—a monoclonal antibody that binds to an inflammatory molecule, IL-4 receptor alfa, and inhibits the inflammatory response that leads to rashes and itching from atopic dermatitis/eczema—may have a positive or negative impact on COVID-19 responses in patients who have the disease.
A new study from Binghamton University, State University of New York may help to peel back the layers of unhealthy skin — at least metaphorically speaking — and get closer to a cure.
A recent study suggests that maternal depression in the postpartum period, and even beyond, is associated with the development of atopic dermatitis throughout childhood and adolescence.
Two medically challenging cases being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting contain new information on the benefits of oral food challenges when diagnosing food allergies.
In a study using non-invasive tape strips in young children with eczema (or atopic dermatitis), researchers found many molecular signs of immune dysfunction and skin changes that relate to disease activity. These signs (or biomarkers) were present even before eczema was visible and can be used to track disease activity over time. With more research, these biomarkers also may help predict response to medicine and development of conditions associated with eczema, such as asthma, other allergies, infections and even attention deficit hyperactivity disorder (ADHD). Findings were published in JAMA Dermatology.
Atopic dermatitis (also known as eczema) is a common skin condition in babies. It affects up to 25% of children, and an estimated 60% of people with eczema develop it during their first year of life. While there is no cure, dermatologists from the American Academy of Dermatology say most cases can be controlled with a customized skin care plan, which may include moisturizers, prescription medications and strategies to eliminate triggers.
English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu